Research articlePublished 2013

shRNA for Thymic Stromal Lymphopoietin: A Novel Therapeutic Approach for Pulmonary Fibrosis

Authors: Tsung-Jen Hung, Shu-Fen Liu, Guo-Zheng Liu, Pei-fang Hsieh, Lea-Yea Chuang, Jinn-Yuh Guh, Chang-Chi Hsieh, Yu-Ju Hung, Yow-Ling Shiue, Yang Yu- Lin

Journal of Cell Science & Therapy

Volume 4 · Issue 3 · Pages 1–9

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Thymic stromal lymphopoietin (TSLP) was recently identified as a master switch for Th2 responses. This study discusses the role of TSLP in pulmonary fibrosis. We show that TGF-β1 (a Fibrogenic Growth Factor) up regulates TSLP proteins in human lung fibroblasts (HFL-1) on a dose- and time-course-dependent basis. Additionally, TSLP increases fibronectin expression on a dose- (1 ng/ml to 100 ng/ml) and time-course-dependent basis concomitantly with the upregulation of pSmad2/3 and Smad4, which is the essential downstream signal regulator for TGF-β. Silencing TSLP by TSLP shRNA dramatically reverses TGF-β1-induced cellular fibrosis concomitantly with the suppression of type I TGF-β receptors and pSmad2/3. Parallel results are observed in vivo. Bleomycin-treated C57BL/6 mice show intense staining for TSLP in fibrotic lung tissue by immunohistochemistry. More importantly, Sirius red and H&E staining from bleomycin-treated mice demonstrate that transfection with TSLP shRNA (by intranasal instillation) dramatically decreases both infiltration of inflammatory cells and deposition of collagen compared to the control. Moreover, a whole-body plethysmography test showed that TSLP shRNA transgenic mice significantly attenuate the increase in airway respiratory resistance induced by bleomycin. Thus, it may be possible to use TSLP shRNA as a novel therapeutic approach for treating pulmonary fibrosis by down-regulating TGF-β signal proteins.

Subjects

Biology

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Longdom does not store it.

Try:

More from this journal

The newest in Journal of Cell Science & Therapy.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Cell Science & Therapy
  • SubjectBiology
  • BylineArticles whose byline prints “Tsung-Jen Hung”
  • BylineArticles whose byline prints “Shu-Fen Liu”
  • BylineArticles whose byline prints “Guo-Zheng Liu”
  • BylineArticles whose byline prints “Pei-fang Hsieh”
  • BylineArticles whose byline prints “Lea-Yea Chuang”
  • BylineArticles whose byline prints “Jinn-Yuh Guh”
  • BylineArticles whose byline prints “Chang-Chi Hsieh”
  • BylineArticles whose byline prints “Yu-Ju Hung”